Molecular Mechanisms of FDA-Approved Drugs for the Treatment of Alzheimer’s Disease: A Comprehensive Review. Molecular Medicine Communications, [S. l.], v. 5, n. 1, p. 17–28, 2025. DOI: 10.55627/mmc.005.01.01795. Disponível em: https://rootspress.org/journals/MMC/article/view/1795. Acesso em: 3 apr. 2026.